Authors



Ming-Chin Yang, DrPH

Latest:

Can Cancer Patients Seeking a Second Opinion Get Better Care?

Colorectal resection patients in Taiwan with heavy hospital shopping behaviors got better surgical care than those who did not shop or hospitals.





David W. Plocher, MD

Latest:

Plan Designs That Encourage the Use of Generic Drugs Over Brand-Name Drugs: An Analysis of a Free Generic Benefit

Small increases and decreases in pharmacy copayments have little influence on patients’ switching to generic drugs or on improving adherence to medication regimens.





Chi-Chen Chen, PhD

Latest:

Reexamining the Association of Care Continuity and Health Care Outcomes

Claims-based and patient-reported continuity measures have distinct effects on subjective and objective outcomes. A claims-based continuity indicator may be a unique dimension of care continuity.


Brigitte C. Madrian, PhD

Latest:

Testimonials Do Not Convert Patients From Brand to Generic Medication

We conducted a randomized controlled trial to assess whether adding a peer testimonial to a mailing increases conversion rates from brand name prescription medications to lower-cost equivalents.




Sara C. Erickson, PharmD

Latest:

Adherence, Persistence, and Switching Patterns of Dabigatran Etexilate

We present a descriptive analysis utilizing pharmacy claims from a managed care population to quantify adherence, persistence, and switching patterns for patients initiating dabigatran.


Jacob Reider, MD

Latest:

The Health Information Technology Special Issue: Has IT Become a Mandatory Part of Health and Healthcare?

The 7th annual Health Information Technology (IT) issue provides a window into how health IT tools are working well, how they may not be working as intended, and what we can do to continue making progress toward optimal use of technology to accomplish our shared goals: better health, better care experience, and lower per capita cost.


Michael Curry, MD

Latest:

Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017

From 2013 to 2017, the population of US patients prescribed treatment for chronic hepatitis C virus (HCV) changed, becoming predominantly treatment-naïve and having received care in nonacademic centers.


Brian Chen, JD, PhD

Latest:

Imposing a Health Insurance Surcharge on the Unvaccinated

Imposing a surcharge on unvaccinated employees will require employers to think through legal and policy implications.





Lisa A. Simpson, MB, BCh, MPH, FAAP

Latest:

That Was Then, This Is Now

When Aligning Forces started, federal policy was a desert. Now it's a greenhouse.


Robert J. LoCasale, PhD

Latest:

Treatment Patterns, Healthcare Utilization, and Costs of Chronic Opioid Treatment for Non-Cancer Pain in the United States

Healthcare utilization and costs increased in the 6 months after patients started opioid therapy for chronic pain; they then decreased but never reverted to baseline levels.




Sara N. Bleich, PhD

Latest:

Validating the Adapted Diabetes Complications Severity Index in Claims Data

The aDCSI without the inclusion of laboratory data performs similarly to the DCSI with laboratory results, and is a good measure of diabetes severity.




Rachel O. Reid, MD, MS

Latest:

Do Localized Disasters Impact Clinical Measures of Health Care Quality?

This study examines the impact of geographically limited disasters on health care quality performance scores of Medicare Advantage contracts, finding limited impact on performance scores.



Anne C. Moorman, BSN, MPH

Latest:

Hepatitis B Virus Infection Testing and Prevalence Among Asian and Pacific Islanders

We examined the effect of country of origin on HBV testing and chronic HBV infection prevalence among APIs using data from Kaiser Permanente Hawaii.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo